These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 740112)

  • 1. Creatinine transfer between red cells and plasma: a comparison between normal and uremic subjects.
    Skalsky M; Schindhelm K; Farrell PC
    Nephron; 1978; 22(4-6):514-21. PubMed ID: 740112
    [No Abstract]   [Full Text] [Related]  

  • 2. Red blood cell membrane permeability of uremic and normal cells.
    Langsdorf LJ; Zydney AL
    ASAIO Trans; 1991; 37(3):M461-2. PubMed ID: 1751237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy metabolism in uremic red cells: relationship of red cell adenosine triphosphate concentration to extracellular phosphate.
    Lichtman MA; Miller DR; Weed RI
    Trans Assoc Am Physicians; 1969; 82():331-43. PubMed ID: 5375156
    [No Abstract]   [Full Text] [Related]  

  • 4. Transerythrocytic concentrations of urea and creatinine in normals and in azotemic patients.
    Dresser TP; Nolph KD; Vitale FC
    Int Urol Nephrol; 1977; 9(2):169-76. PubMed ID: 591243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the distribution of urea and creatinine between red cells and plasma in normal and azotemic blood as assessed by autoanalyzer and manual chemical methods.
    Nolph K; Felts J; Moore R; Van Stone J
    Int Urol Nephrol; 1978; 10(1):59-64. PubMed ID: 649287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of uremia on the membrane transport characteristics of red blood cells.
    Langsdorf LJ; Zydney AL
    Blood; 1993 Feb; 81(3):820-7. PubMed ID: 8427973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of insulin binding to erythrocytes in plasma of uremic patients.
    Milutinović S; Breyer D; Janković N; Molnar V; Stefović A; Rocić B
    Nephron; 1983; 34(2):99-103. PubMed ID: 6346120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and metabolic studies on red blood cell sodium transport in chronic uremia.
    Kramer HJ; Gospodinov D; Krück F
    Nephron; 1976; 16(5):344-58. PubMed ID: 131254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hemoperfusion on plasma oxidizing capacity and erythrocyte sensitivity to oxidation in patients with chronic uremia].
    Trznadel K; Luciak M; Mamczur D; Kroczak M; Zbróg Z; Kidawa Z
    Pol Tyg Lek; 1989 Feb; 44(9):226-8. PubMed ID: 2813185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.
    Cheng JT; Kahn T; Kaji DM
    J Clin Invest; 1984 Nov; 74(5):1811-20. PubMed ID: 6094614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The red blood cell as a model for the study of uremic toxins.
    Smith EK; Welt LG
    Arch Intern Med; 1970 Nov; 126(5):827-30. PubMed ID: 4248903
    [No Abstract]   [Full Text] [Related]  

  • 13. Pentose phosphate pathway of erythrocytes in uremia.
    Markkanen T; Peltola O; Forsström J; Himanen P
    Acta Haematol; 1972; 48(5):269-77. PubMed ID: 4630658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the inhibitor of glucose utilization, isolated from serum of patients in uremia, upon morphology and membrane permeability of erythrocytes (author's transl)].
    Gajdos M; Dzúrik R
    Bratisl Lek Listy; 1974; 62(1):29-34. PubMed ID: 4848602
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of ionic permeability in a nonpolarized cell: effect of cAMP.
    London RD; Lipkowitz MS; Sinert RH; Abramson RG
    Am J Physiol; 1989 Dec; 257(6 Pt 2):F985-93. PubMed ID: 2557768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes.
    Gallice P; Lai E; Brunet P; Berland Y; Elsen R; Crevat A
    Int J Artif Organs; 1993 Mar; 16(3):120-2. PubMed ID: 8390969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of transcellular transport kinetics of urea and creatinine for haemodialysis (author's transl)].
    Zimmermann E; Pölz E
    Wien Klin Wochenschr; 1981 Sep; 93(16):519-21. PubMed ID: 7303697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determination of whole blood magnesium concentration in uremics on chronic dialysis.
    Gonella M; Buzzigoli G; Bencivelli W; Bartolini V; Betti G
    Nephron; 1981; 28(2):88-9. PubMed ID: 7290276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbate-cyanide test on red blood cells in uremia: effect of guanidinopropionic acid.
    Kamoun PP; Zingraff JJ; Turlin G; Lebreton P
    Nephron; 1981; 28(1):26-9. PubMed ID: 7266724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes.
    Eloot S; Torremans A; De Smet R; Marescau B; De Deyn PP; Verdonck P; Vanholder R
    Am J Kidney Dis; 2007 Aug; 50(2):279-88. PubMed ID: 17660029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.